Not yet clear

Extract from the above information

The prototype of this product is inactive and is converted into the active metabolite desglymidodrine through metabolism. Desglymidodrine is a selective peripheral sympathetic a1 receptor agonist, which acts directly on the postsynapse to release adrenaline stimulants. It has the function of regulating vascular tension, can increase peripheral arterial and venous resistance, prevent blood congestion in the lower limbs, promote blood return, stabilize blood volume, increase upright blood pressure, and improve symptoms caused by insufficient circulation volume; it will not cause increased excitability of the central nervous system and has no direct effect on the heart, but the heart rate may decrease due to feedback after taking the drug.

Mycophenolate mofetil (MMF) is a 2-ethyl ester derivative of mycophenolic acid (MPA). MPA is a highly effective, selective, non-competitive, and reversible inhibitor of inosine mononucleotide dehydrogenase (IMPDH), which can inhibit the classical synthesis pathway of guanine nucleotides. MPA has a highly selective effect on lymphocytes. Mycophenolate mofetil tablets are extremely effective in preventing rejection after renal transplantation and treating refractory rejection.

Extract from the above information